Alzheimer Study

The following study focuses on Alzheimer’s treatment rather than prevention and is open to people who have been diagnosed with (or shown signs of) Alzheimer’s or dementia.
If you know someone who might be able to participate, please consider connecting them with the researchers. Study details and contact information are below.

Title: NOURISH AD

Sponsor: Accera

Brief study summary: NOURISH AD is a clinical research study where doctors are testing an investigational new drug to see if it may improve memory and thinking processes in people with mild to moderate Alzheimer’s disease.

About the study: The NOURISH AD study is being conducted to help advance research in treatments for mild to moderate Alzheimer’s disease and to test the safety and effectiveness of an investigational drug called AC-1204.

Additional details about the study include:
• The study is being conducted at up to 90 sites across the US.
• The study length is approximately 7 months which includes a screening period of about 1 month and a 6 month treatment period.
• A placebo is being used for this trial. However, after the first 6 month treatment period of the study, all patients are eligible to continue treatment for another 6 months, where everyone receives the study drug, AC-1204.
• All study-related medications, medical care, laboratory testing, clinic visits, memory testing and other study procedures are free.

Purpose: Research studies have shown that the brains of people with Alzheimer’s disease often have difficulty using glucose.
Glucose, a simple form of sugar, is the brain’s primary source of energy.
Your body also makes ketone bodies, another energy source that your brain can use in place of glucose.

The purpose of this study is to see whether increasing ketone body levels with an investigational new drug called AC-1204, will improve test scores that measure memory and other mental skills in people with Alzheimer’s disease.
What is involved?:
• People who qualify for this research study may continue taking their current Alzheimer’s disease medication during the study.
• Health insurance is not required, and a referral from your current doctor is not needed.
• There are five (5) study clinic visits and three (3) phone calls during the first part of the study. This study does not require overnight stays.

People who qualify may receive:
• Investigational treatment for Alzheimer’s symptoms
• Study-related care from a local Alzheimer’s expert
• Compensation for time and travel

Eligibility criteria: You must meet the following criteria:
• Be between 66 and 90 years old
• Have mild to moderate Alzheimer’s disease or memory problems
• Have a dedicated caregiver available who can attend study visits with you
• Meet other study requirements as determined by the study doctor

Eligibility age: 66-90 years old

Study locations: The NOURISH AD Study is currently enrolling at multiple locations within the US. If you’re interested in exploring this option go to www.newhopeclinicalresearch.com or call: 704-817-7732 to see if you or a loved one might qualify and to find a study location near you.